Boehringer Ingelheim, a privately held pharmaceutical company with a campus in Ridgebury, announced a few highlights of the 2013 fiscal year: The firm increased operating income and return on net sales; net sales reached about €14.1 billion, which represents an increase of 1.4%, currency-adjusted (-4.3% in euro terms); there was a 2.4% improvement in the return on net sales to 15%; the company expects net sales in 2014 to remain at a comparable level to 2013; the firm now employs more than 47,400 people worldwide, a 3% increase over last year.
The full annual report is available on boehringer-ingelheim.com and as an app for iOS and android devices on the App Store and at Google Play.